NPI Details
INTERPACE DIAGNOSTICS CORPORATION is a clinical medical laboratory in Pittsburgh, PA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. INTERPACE DIAGNOSTICS CORPORATION NPI is 1609826304. The provider is registered as an organization entity type.
The provider Former Legal Business Name Is Redpath Integrated Pathology, Inc..
The provider's business location address is:
2515 LIBERTY AVE
PITTSBURGH, PA
ZIP 15222-613
Phone: (412) 224-6100
Fax: (412) 224-6110
The provider's authorized official is Thomas W Burnell .
The authorized official title is President And Ceo and has the following contact phone number (402) 613-4184.
The CLIA number assigned to this NPI record is 39D1024654 - hospital with a certificate type of Certificate of Accreditation.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Molecular pathology procedure (HCPCS:81479)
- Gene analysis of 10 genes and 37 rna fusions and expression of 4 mrna markers, next-generation sequencing, in fine needle aspirate of thyroid to evaluate risk of thyroid cancer (HCPCS:0245U)
- Microrna gene analysis of thyroid nodule tissue (HCPCS:0018U)
- Amylase (enzyme) level (HCPCS:82150)
- Preparation of specimen, manual (HCPCS:88381)
- Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
- Glucose (sugar) level on body fluid (HCPCS:82945)
The enumeration date for this NPI number is 5/11/2006 and was last updated on 6/29/2021.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | 39D1024654 | PENNSYLVANIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 001686800 | OTHER | PENNSYLVANIA | HIGHMARK BS |
| 2 | 101-855-645-000-1 | MEDICAID | PENNSYLVANIA | |
